Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Early hair loss may indicate prostate issues.

In vivo confocal scanning laser microscopy is an effective, non-invasive way to study and measure new hair growth after skin injury in mice.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

New techniques for treating scalp blood vessel malformations are effective and can have good cosmetic results.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.